| Year |
Citation |
Score |
| 2023 |
Figgatt MC, Hincapie-Castillo JM, Schranz AJ, Dasgupta N, Edwards JK, Jackson BE, Marshall SW, Golightly YM. Medications for opioid use disorder and mortality and hospitalization among people with opioid use-related infections. Epidemiology (Cambridge, Mass.). PMID 37820243 DOI: 10.1097/EDE.0000000000001681 |
0.334 |
|
| 2023 |
Bedard ML, Nowlan AC, Martin Del Campo Z, Miller C, Dasgupta N, McElligott ZA. All Hands on Deck: We Need Multiple Approaches To Uncover the Neuroscience behind the Opioid Overdose Crisis. Acs Chemical Neuroscience. PMID 37159430 DOI: 10.1021/acschemneuro.2c00818 |
0.325 |
|
| 2022 |
Maierhofer CN, Ranapurwala SI, DiPrete BL, Fulcher N, Ringwalt CL, Chelminski PR, Ives TJ, Dasgupta N, Go VF, Pence BW. Intended and unintended consequences: Changes in opioid prescribing practices for postsurgical, acute, and chronic pain indications following two policies in North Carolina, 2012-2018 - Controlled and single-series interrupted time series analyses. Drug and Alcohol Dependence. 242: 109727. PMID 36516549 DOI: 10.1016/j.drugalcdep.2022.109727 |
0.301 |
|
| 2022 |
Gertner AK, Dasgupta N, Vincent L. The North American opioid crisis: draw on the expertise of people who use drugs. Lancet (London, England). 400: 1401-1402. PMID 36273474 DOI: 10.1016/S0140-6736(22)01590-2 |
0.346 |
|
| 2022 |
Miracle DK, Slavova S, Brown JR, Dasgupta N, Harris S, Freeman PR. Accuracy and validity of reported opioid prescription days' supply. Pharmacoepidemiology and Drug Safety. PMID 36053913 DOI: 10.1002/pds.5528 |
0.332 |
|
| 2022 |
Oyler DR, Slavova S, Brown JR, Dasgupta N, Freeman PR. Kentucky pharmacists' experiences in dispensing abuse-deterrent opioid analgesics. Journal of the American Pharmacists Association : Japha. PMID 36031547 DOI: 10.1016/j.japh.2022.07.017 |
0.377 |
|
| 2022 |
DiPrete BL, Ranapurwala SI, Maierhofer CN, Fulcher N, Chelminski PR, Ringwalt CL, Ives TJ, Dasgupta N, Go VF, Pence BW. Association of Opioid Dose Reduction With Opioid Overdose and Opioid Use Disorder Among Patients Receiving High-Dose, Long-term Opioid Therapy in North Carolina. Jama Network Open. 5: e229191. PMID 35476064 DOI: 10.1001/jamanetworkopen.2022.9191 |
0.375 |
|
| 2021 |
Dasgupta N, Brown JR, Nocera M, Lazard A, Slavova S, Freeman PR. Abuse-Deterrent Opioids: A Survey of Physician Beliefs, Behaviors, and Psychology. Pain and Therapy. PMID 34870790 DOI: 10.1007/s40122-021-00343-z |
0.309 |
|
| 2021 |
Young JC, Dasgupta N, Chidgey BA, Stürmer T, Pate V, Hudgens M, Jonsson Funk M. Impacts of Initial Prescription Length and Prescribing Limits on Risk of Prolonged Postsurgical Opioid Use. Medical Care. PMID 34812786 DOI: 10.1097/MLR.0000000000001663 |
0.359 |
|
| 2021 |
Blackburn NA, Joniak-Grant E, Nocera M, Dorris SW, Dasgupta N, Chelminski PR, Carey TS, Wu LT, Edwards DA, Marshall SW, Ranapurwala SI. Implementation of mandatory opioid prescribing limits in North Carolina: healthcare administrator and prescriber perspectives. Bmc Health Services Research. 21: 1191. PMID 34732177 DOI: 10.1186/s12913-021-07230-5 |
0.37 |
|
| 2021 |
Shiue KY, Dasgupta N, Naumann RB, Nelson AE, Golightly YM. Sociodemographic and Clinical Predictors of Prescription Opioid Use in a Longitudinal Community-Based Cohort Study of Middle-Aged and Older Adults. Journal of Aging and Health. 8982643211039338. PMID 34404244 DOI: 10.1177/08982643211039338 |
0.32 |
|
| 2021 |
Maierhofer CN, Ranapurwala SI, DiPrete BL, Fulcher N, Ringwalt CL, Chelminski PR, Ives TJ, Dasgupta N, Go VF, Pence BW. Association between statewide opioid prescribing interventions and opioid prescribing patterns in North Carolina, 2006-2018. Pain Medicine (Malden, Mass.). PMID 34175958 DOI: 10.1093/pm/pnab181 |
0.339 |
|
| 2020 |
Brown JR, Oh G, Wang Y, Slavova S, Delcher C, Dasgupta N, Freeman PR. Variation in Abuse-Deterrent Formulation Opioid Prescribing in California, Florida, and Kentucky in 2018. The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association. PMID 32686223 DOI: 10.1111/Jrh.12496 |
0.482 |
|
| 2020 |
Alexandridis AA, Dasgupta N, Ringwalt CL, Rosamond WD, Chelminski PR, Marshall SW. Association between opioid analgesic therapy and initiation of buprenorphine management: An analysis of prescription drug monitoring program data. Plos One. 15: e0227350. PMID 31923197 DOI: 10.1371/Journal.Pone.0227350 |
0.483 |
|
| 2020 |
Shiue K, Dasgupta N, Naumann R, Nelson A, Golightly Y. 105 Sociodemographic and clinical predictors of prescription opioid use in a longitudinal community-based cohort study Injury Prevention. 26. DOI: 10.1136/Injuryprev-2020-Savir.36 |
0.427 |
|
| 2019 |
Young JC, Dasgupta N, Chidgey BA, Jonsson Funk M. Postsurgical Opioid Prescriptions and Risk of Long-term Use: An Observational Cohort Study Across the United States. Annals of Surgery. PMID 31404007 DOI: 10.1097/Sla.0000000000003549 |
0.435 |
|
| 2019 |
Young JC, Jonsson Funk M, Dasgupta N. Medical Use of Long-term Extended-release Opioid Analgesics in Commercially Insured Adults in the United States. Pain Medicine (Malden, Mass.). PMID 31340004 DOI: 10.1093/Pm/Pnz155 |
0.449 |
|
| 2019 |
Dasgupta N, Schwarz J, Hennessy S, Ertefaie A, Dart RC. Causal inference for evaluating prescription opioid abuse using trend-in-trend design. Pharmacoepidemiology and Drug Safety. PMID 30714239 DOI: 10.1002/Pds.4736 |
0.467 |
|
| 2019 |
Alexandridis AA, Dasgupta N, McCort AD, Ringwalt CL, Rosamond WD, Chelminski PR, Marshall SW. Associations between implementation of Project Lazarus and opioid analgesic dispensing and buprenorphine utilization in North Carolina, 2009-2014. Injury Epidemiology. 6: 2. PMID 30663005 DOI: 10.1186/S40621-018-0179-2 |
0.446 |
|
| 2018 |
Iwanicki JL, Severtson SG, Margolin Z, Dasgupta N, Green JL, Dart RC. Consistency Between Opioid-Related Mortality Trends Derived From Poison Center and National Vital Statistics System, United States, 2006-2016. American Journal of Public Health. 108: 1639-1645. PMID 30403501 DOI: 10.2105/AJPH.2018.304728 |
0.35 |
|
| 2018 |
Dasgupta N. "He Is the Object of Information": The Intersection of Big Data and the Opioid Crisis. American Journal of Public Health. 108: 1122-1123. PMID 30089004 DOI: 10.2105/Ajph.2018.304601 |
0.446 |
|
| 2018 |
Dasgupta N, Saucier R, Wolfe D. Authors' Response to Silverman and Colleagues' Comment on "Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence". Drug Safety. PMID 29956219 DOI: 10.1007/S40264-018-0692-9 |
0.423 |
|
| 2018 |
Young JC, Lund JL, Dasgupta N, Jonsson Funk M. Opioid tolerance and clinically recognized opioid poisoning among patients prescribed extended-release long-acting opioids. Pharmacoepidemiology and Drug Safety. PMID 29888409 DOI: 10.1002/Pds.4572 |
0.485 |
|
| 2018 |
Ranapurwala SI, Naumann RB, Austin AE, Dasgupta N, Marshall SW. Methodologic limitations of prescription opioid safety research and recommendations for improving the evidence base. Pharmacoepidemiology and Drug Safety. PMID 29862602 DOI: 10.1002/Pds.4564 |
0.496 |
|
| 2018 |
Saucier R, Wolfe D, Dasgupta N. Correction to: Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence. Drug Safety. PMID 29796833 DOI: 10.1007/S40264-018-0685-8 |
0.432 |
|
| 2018 |
Murphy DL, Lebin JA, Severtson SG, Olsen HA, Dasgupta N, Dart RC. Comparative Rates of Mortality and Serious Adverse Effects Among Commonly Prescribed Opioid Analgesics. Drug Safety. PMID 29582394 DOI: 10.1007/s40264-018-0660-4 |
0.387 |
|
| 2018 |
Saucier R, Wolfe D, Dasgupta N. Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence. Drug Safety. PMID 29560596 DOI: 10.1007/S40264-018-0653-3 |
0.46 |
|
| 2018 |
Ringwalt C, Sanford C, Dasgupta N, Alexandridis A, McCort A, Proescholdbell S, Sachdeva N, Mack K. Community Readiness to Prevent Opioid Overdose. Health Promotion Practice. 1524839918756887. PMID 29400083 DOI: 10.1177/1524839918756887 |
0.457 |
|
| 2018 |
Dasgupta N. Evaluating difficult-to-crush opioids in the community. The Lancet. Psychiatry. PMID 29336949 DOI: 10.1016/S2215-0366(18)30004-X |
0.409 |
|
| 2017 |
Dart RC, Iwanicki JL, Dasgupta N, Cicero TJ, Schnoll SH. Do abuse deterrent opioid formulations work? Journal of Opioid Management. 13: 365-378. PMID 29308584 DOI: 10.5055/jom.2017.0415 |
0.371 |
|
| 2017 |
Dasgupta N, Beletsky L, Ciccarone D. Opioid Crisis: No Easy Fix to Its Social and Economic Determinants. American Journal of Public Health. e1-e5. PMID 29267060 DOI: 10.2105/AJPH.2017.304187 |
0.356 |
|
| 2017 |
Alexandridis AA, McCort A, Ringwalt CL, Sachdeva N, Sanford C, Marshall SW, Mack K, Dasgupta N. A statewide evaluation of seven strategies to reduce opioid overdose in North Carolina. Injury Prevention : Journal of the International Society For Child and Adolescent Injury Prevention. PMID 28835443 DOI: 10.1136/Injuryprev-2017-042396 |
0.425 |
|
| 2017 |
Gilbert M, Dasgupta N. Silicon to syringe: Cryptomarkets and disruptive innovation in opioid supply chains. The International Journal On Drug Policy. PMID 28735772 DOI: 10.1016/J.Drugpo.2017.05.052 |
0.349 |
|
| 2017 |
Anderson L, Bell HG, Gilbert M, Davidson JE, Winter C, Barratt MJ, Win B, Painter JL, Menone C, Sayegh J, Dasgupta N. Using Social Listening Data to Monitor Misuse and Nonmedical Use of Bupropion: A Content Analysis. Jmir Public Health and Surveillance. 3: e6. PMID 28148472 DOI: 10.2196/Publichealth.6174 |
0.31 |
|
| 2016 |
Severtson SG, Ellis MS, Kurtz SP, Rosenblum A, Cicero TJ, Parrino MW, Gilbert MK, Buttram ME, Dasgupta N, BucherBartelson B, Green JL, Dart RC. Sustained reduction of diversion and abuse after introduction of an abuse deterrent formulation of extended release oxycodone. Drug and Alcohol Dependence. 168: 219-229. PMID 27716575 DOI: 10.1016/J.Drugalcdep.2016.09.018 |
0.354 |
|
| 2015 |
Dart RC, Surratt HL, Le Lait MC, Stivers Y, Bebarta VS, Freifeld CC, Brownstein JS, Burke JJ, Kurtz SP, Dasgupta N. Diversion and Illicit Sale of Extended Release Tapentadol in the United States. Pain Medicine (Malden, Mass.). PMID 26814267 DOI: 10.1093/Pm/Pnv032 |
0.463 |
|
| 2015 |
Dasgupta N, Funk MJ, Proescholdbell S, Hirsch A, Ribisl KM, Marshall S. Cohort Study of the Impact of High-dose Opioid Analgesics on Overdose Mortality. Pain Medicine (Malden, Mass.). PMID 26333030 DOI: 10.1111/Pme.12907 |
0.584 |
|
| 2015 |
Conover MM, Howell JO, Wu JM, Kinlaw AC, Dasgupta N, Jonsson Funk M. Incidence of opioid-managed pelvic pain after hysteroscopic sterilization versus laparoscopic sterilization, US 2005-2012. Pharmacoepidemiology and Drug Safety. PMID 25832014 DOI: 10.1002/Pds.3766 |
0.367 |
|
| 2015 |
Webster LR, Reisfield GM, Dasgupta N. Eight principles for safer opioid prescribing and cautions with benzodiazepines. Postgraduate Medicine. 127: 27-32. PMID 25526233 DOI: 10.1080/00325481.2015.993276 |
0.459 |
|
| 2015 |
Dasgupta N, Funk MJ, Proescholdbell S, Hirsch A, Ribisl KM, Marshall S. Cohort Study of the Impact of High-dose Opioid Analgesics on Overdose Mortality Pain Medicine (United States). DOI: 10.1111/pme.12907 |
0.552 |
|
| 2015 |
Lait MCL, Severtson SG, Dasgupta N, Green JL, Hall A, Dart RC. The street prices of immediate- and extended-release tapentadol are lower than other schedule II opioid tablets/capsules Drug and Alcohol Dependence. 146. DOI: 10.1016/J.Drugalcdep.2014.09.382 |
0.312 |
|
| 2014 |
Dasgupta N, Creppage K, Austin A, Ringwalt C, Sanford C, Proescholdbell SK. Observed transition from opioid analgesic deaths toward heroin. Drug and Alcohol Dependence. 145: 238-41. PMID 25456574 DOI: 10.1016/J.Drugalcdep.2014.10.005 |
0.474 |
|
| 2014 |
Hirsch A, Proescholdbell SK, Bronson W, Dasgupta N. Prescription histories and dose strengths associated with overdose deaths. Pain Medicine (Malden, Mass.). 15: 1187-95. PMID 25202775 DOI: 10.1111/Pme.12391 |
0.459 |
|
| 2014 |
Gerlach KK, Dasgupta N, Schnoll SH, Henningfield JE. Epidemiology of stimulant misuse and abuse: implications for future epidemiologic and neuropharmacologic research. Neuropharmacology. 87: 91-6. PMID 24813641 DOI: 10.1016/J.Neuropharm.2014.04.020 |
0.315 |
|
| 2014 |
Ringwalt C, Gugelmann H, Garrettson M, Dasgupta N, Chung AE, Proescholdbell SK, Skinner AC. Differential prescribing of opioid analgesics according to physician specialty for Medicaid patients with chronic noncancer pain diagnoses. Pain Research & Management : the Journal of the Canadian Pain Society = Journal De La SociéTé Canadienne Pour Le Traitement De La Douleur. 19: 179-85. PMID 24809067 DOI: 10.1155/2014/857952 |
0.46 |
|
| 2014 |
Freifeld CC, Brownstein JS, Menone CM, Bao W, Filice R, Kass-Hout T, Dasgupta N. Digital drug safety surveillance: monitoring pharmaceutical products in twitter. Drug Safety. 37: 343-50. PMID 24777653 DOI: 10.1007/S40264-014-0155-X |
0.302 |
|
| 2013 |
Dasgupta N, Freifeld C, Brownstein JS, Menone CM, Surratt HL, Poppish L, Green JL, Lavonas EJ, Dart RC. Crowdsourcing black market prices for prescription opioids. Journal of Medical Internet Research. 15: e178. PMID 23956042 DOI: 10.2196/Jmir.2810 |
0.438 |
|
| 2013 |
Dasgupta N. Defining Controlled Substances Overdose: Should Deaths from Substance Use Disorders and Pharmaceutical Adverse Events be included? Journal of Clinical Toxicology. 3. DOI: 10.4172/2161-0495.1000164 |
0.363 |
|
| 2012 |
Dasgupta N, Davis J, Jonsson Funk M, Dart R. Using poison center exposure calls to predict methadone poisoning deaths. Plos One. 7: e41181. PMID 22829925 DOI: 10.1371/Journal.Pone.0041181 |
0.328 |
|
| 2012 |
Turk DC, O'Connor AB, Dworkin RH, Chaudhry A, Katz NP, Adams EH, Brownstein JS, Comer SD, Dart R, Dasgupta N, Denisco RA, Klein M, Leiderman DB, Lubran R, Rappaport BA, et al. Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations. Pain. 153: 1997-2008. PMID 22770841 DOI: 10.1016/J.Pain.2012.05.029 |
0.462 |
|
| 2012 |
Heimer R, Dasgupta N, Irwin KS, Kinzly M, Harvey AP, Givens A, Grau LE. Chronic pain, addiction severity, and misuse of opioids in Cumberland County, Maine. Addictive Behaviors. 37: 346-9. PMID 22138379 DOI: 10.1016/J.Addbeh.2011.11.017 |
0.397 |
|
| 2011 |
Dasgupta N, Henningfield JE, Ertischek MD, Schnoll SH. When drugs in the same controlled substance schedule differ in real-world abuse, should they be differentiated in labeling? Drug and Alcohol Dependence. 119: e1-4. PMID 21704462 DOI: 10.1016/J.Drugalcdep.2011.05.013 |
0.366 |
|
| 2011 |
Webster LR, Dasgupta N. Obtaining adequate data to determine causes of opioid-related overdose deaths. Pain Medicine (Malden, Mass.). 12: S86-92. PMID 21668762 DOI: 10.1111/J.1526-4637.2011.01132.X |
0.466 |
|
| 2011 |
Albert S, Brason FW, Sanford CK, Dasgupta N, Graham J, Lovette B. Project Lazarus: community-based overdose prevention in rural North Carolina. Pain Medicine (Malden, Mass.). 12: S77-85. PMID 21668761 DOI: 10.1111/J.1526-4637.2011.01128.X |
0.433 |
|
| 2011 |
Webster LR, Cochella S, Dasgupta N, Fakata KL, Fine PG, Fishman SM, Grey T, Johnson EM, Lee LK, Passik SD, Peppin J, Porucznik CA, Ray A, Schnoll SH, Stieg RL, et al. An analysis of the root causes for opioid-related overdose deaths in the United States. Pain Medicine (Malden, Mass.). 12: S26-35. PMID 21668754 DOI: 10.1111/J.1526-4637.2011.01134.X |
0.419 |
|
| 2011 |
Wolfe D, Carrieri MP, Dasgupta N, Wodak A, Newman R, Bruce RD. Concerns about injectable naltrexone for opioid dependence. Lancet (London, England). 377: 1468-70. PMID 21529930 DOI: 10.1016/S0140-6736(10)62056-9 |
0.457 |
|
| 2011 |
Wolfe D, Carrieri MP, Dasgupta N, Bruce D, Wodak A. Injectable extended-release naltrexone for opioid dependence - Authors' reply The Lancet. 378: 666. DOI: 10.1016/S0140-6736(11)61333-0 |
0.436 |
|
| 2010 |
Dasgupta N, Bailey EJ, Cicero T, Inciardi J, Parrino M, Rosenblum A, Dart RC. Post-marketing surveillance of methadone and buprenorphine in the United States. Pain Medicine (Malden, Mass.). 11: 1078-91. PMID 20545875 DOI: 10.1111/J.1526-4637.2010.00877.X |
0.451 |
|
| 2010 |
Dasgupta N, Sanford C, Albert S, Brason FW. Opioid Drug Overdoses: A Prescription for Harm and Potential for Prevention American Journal of Lifestyle Medicine. 4: 32-37. DOI: 10.1177/1559827609348462 |
0.487 |
|
| 2009 |
Dasgupta N, Mandl KD, Brownstein JS. Breaking the news or fueling the epidemic? Temporal association between news media report volume and opioid-related mortality. Plos One. 4: e7758. PMID 19924221 DOI: 10.1371/Journal.Pone.0007758 |
0.466 |
|
| 2008 |
Dasgupta N, Funk MJ, Brownstein JS. Comparing unintentional opioid poisoning mortality in metropolitan and non-metropolitan counties, United States, 1999-2003 Geography and Drug Addiction. 175-192. DOI: 10.1007/978-1-4020-8509-3_11 |
0.358 |
|
| 2007 |
Grau LE, Dasgupta N, Harvey AP, Irwin K, Givens A, Kinzly ML, Heimer R. Illicit use of opioids: is OxyContin a "gateway drug"? The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 16: 166-73. PMID 17612819 DOI: 10.1080/10550490701375293 |
0.324 |
|
| 2006 |
Dasgupta N, Kramer ED, Zalman MA, Carino S, Smith MY, Haddox JD, Wright C. Association between non-medical and prescriptive usage of opioids. Drug and Alcohol Dependence. 82: 135-42. PMID 16236466 DOI: 10.1016/j.drugalcdep.2005.08.019 |
0.416 |
|
| Show low-probability matches. |